Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 16.3× sales vs its 25.5× historical median P/S.
Fair value ≈ $0.05 · price $0.03 today
Undervalued · 36% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AIMLF WoW 🤮
Another monster Dilution .. Got to keep Management in over paid salaries !
WHAT accomplishments has been returned?
And WHY are you ashamed of disclosure to American traders ?
Shite S. C. A. M.
$AIMLF $AIML.CSE is pleased to announce the appointment of Paul Dorian, MD, MSc, as its medical innovation architect (MIA) and head of the company's medical advisory board, effective immediately
https://biotuesdays.com/2026/01/28/aiml-names-dr-paul-dorian-mia-and-head-of-medical-advisory-board/
$AIMLF $IDKFF ... Pure TRAIN WRECK 🪨 🚄
Look 👀 at these numbers. How management can reward themselves
ONE MILLION DOLLARS , on only $100K Revenue.
And $600K for "Consultants " ? 🤡
( Not to mention the scam of buying 'Quantum' see earlier posts)
$IDKFF Why Small Cap Stocks & Crypto Are Making a Comeback 👀
https://youtube.com/shorts/FNVLf_Djt7c?si=E8bioKoEH-NLPEUb
$HYPC.X $AIMLF $AIML.CSE $DNX.X $DMC
